{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:03:23Z","timestamp":1792206203284,"version":"4.4.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04185-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:16:05Z","timestamp":1769505365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["New genomic and proteomic biomarker discovery in cancer: revolutionizing diagnosis and prognostication"],"prefix":"10.1186","volume":"24","author":[{"given":"Monika","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhi","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"3","key":"4185_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834 Epub 2024 Apr 4. PMID: 38572751.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4185_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.121.3.439","volume":"121","author":"P Gold","year":"1965","unstructured":"Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121(3):439\u201362. https:\/\/doi.org\/10.1084\/jem.121.3.439. PMID: 14270243; PMCID: PMC2137957.","journal-title":"J Exp Med"},{"issue":"13","key":"4185_CR3","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, M\u00e4\u00e4tt\u00e4nen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A. ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320\u20138. https:\/\/doi.org\/10.1056\/NEJMoa0810084. Epub 2009 Mar 18. PMID: 19297566.","journal-title":"N Engl J Med"},{"key":"4185_CR4","doi-asserted-by":"publisher","unstructured":"Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature. 1979;278(5701):261-3. https:\/\/doi.org\/10.1038\/278261a0. PMID: 218111.","DOI":"10.1038\/278261a0"},{"key":"4185_CR5","doi-asserted-by":"publisher","unstructured":"Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986 Oct 16\u201322;323(6089):643-6. https:\/\/doi.org\/10.1038\/323643a0. PMID: 2877398.","DOI":"10.1038\/323643a0"},{"key":"4185_CR6","doi-asserted-by":"publisher","unstructured":"Barbacid M. ras genes. Annu Rev Biochem. 1987;56:779\u2013827. https:\/\/doi.org\/10.1146\/annurev.bi.56.070187.004023. PMID: 3304147.","DOI":"10.1146\/annurev.bi.56.070187.004023"},{"issue":"25","key":"4185_CR7","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","volume":"384","author":"F Skoulidis","year":"2021","unstructured":"Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R. Sotorasib for lung cancers with KRAS p.G12C mutation. N Engl J Med. 2021;384(25):2371\u201381. https:\/\/doi.org\/10.1056\/NEJMoa2103695. Epub 2021 Jun 4. PMID: 34096690; PMCID: PMC9116274.","journal-title":"N Engl J Med"},{"key":"4185_CR8","doi-asserted-by":"publisher","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66\u201371. https:\/\/doi.org\/10.1126\/science.7545954. PMID: 7545954.","DOI":"10.1126\/science.7545954"},{"key":"4185_CR9","doi-asserted-by":"publisher","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995 Dec 21\u201328;378(6559):789\u2009\u2013\u200992. https:\/\/doi.org\/10.1038\/378789a0. Erratum in: Nature 1996;379(6567):749. PMID: 8524414.","DOI":"10.1038\/378789a0"},{"key":"4185_CR10","doi-asserted-by":"publisher","unstructured":"Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467\u2009\u2013\u200970. https:\/\/doi.org\/10.1126\/science.270.5235.467. PMID: 7569999.","DOI":"10.1126\/science.270.5235.467"},{"key":"4185_CR11","doi-asserted-by":"publisher","unstructured":"Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198\u2013207. https:\/\/doi.org\/10.1038\/nature01511. PMID: 12634793.","DOI":"10.1038\/nature01511"},{"issue":"21","key":"4185_CR12","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350(21):2129\u201339. https:\/\/doi.org\/10.1056\/NEJMoa040938. Epub 2004 Apr 29. PMID: 15118073.","journal-title":"N Engl J Med"},{"issue":"9","key":"4185_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O\u2019Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1002011. PMID: 20818844; PMCID: PMC3724529.","journal-title":"N Engl J Med"},{"key":"4185_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-019-1741-2","volume":"17","author":"N Batta","year":"2019","unstructured":"Batta N, Pandey M. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance. World J Surg Oncol. 2019;17:1\u20132.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4185_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-025-10607-y","volume":"52","author":"R Dixit","year":"2025","unstructured":"Dixit R, Pandey M, Shukla VK. Bioprospecting potential genetic biomarkers of gallbladder cancer. Mol Biol Rep. 2025;52(1):1\u20134.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"4185_CR16","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.1007\/s11033-022-07448-4","volume":"49","author":"R Dixit","year":"2022","unstructured":"Dixit R, Pandey M, Rajput M, Shukla VK. Unravelling of the comparative transcriptomic profile of gallbladder cancer using mRNA sequencing. Mol Biol Rep. 2022;49(7):6395\u2013403.","journal-title":"Mol Biol Rep"},{"issue":"27","key":"4185_CR17","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326. https:\/\/doi.org\/10.1056\/NEJMoa041588. Epub 2004 Dec 10. PMID: 15591335.","journal-title":"N Engl J Med"},{"key":"4185_CR18","doi-asserted-by":"publisher","unstructured":"van \u2018t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530-6. https:\/\/doi.org\/10.1038\/415530a. PMID: 11823860.","DOI":"10.1038\/415530a"},{"issue":"5897","key":"4185_CR19","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897):1807\u201312. https:\/\/doi.org\/10.1126\/science.1164382. Epub 2008 Sep 4. PMID: 18772396; PMCID: PMC2820389.","journal-title":"Science"},{"issue":"7","key":"4185_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1612674","volume":"376","author":"TS Mok","year":"2017","unstructured":"Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA. AURA3 Investigators. Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive lung cancer. N Engl J Med. 2017;376(7):629\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1612674. Epub 2016 Dec 6. PMID: 27959700; PMCID: PMC6762027.","journal-title":"N Engl J Med"},{"key":"4185_CR21","unstructured":"FDA. (2020). FDA approves first liquid biopsy next-generation sequencing companion diagnostic test. FDA News Release. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test [Accessed 10 Jul 2025]."},{"key":"4185_CR22","doi-asserted-by":"publisher","unstructured":"Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11):845\u2009\u2013\u200967. https:\/\/doi.org\/10.1074\/mcp.r200007-mcp200. Erratum in: Mol Cell Proteomics. 2003;2(1):50. PMID: 12488461.","DOI":"10.1074\/mcp.r200007-mcp200"},{"key":"4185_CR23","doi-asserted-by":"publisher","unstructured":"Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics. 2002;1(5):376\u2009\u2013\u200986. https:\/\/doi.org\/10.1074\/mcp.m200025-mcp200. PMID: 12118079.","DOI":"10.1074\/mcp.m200025-mcp200"},{"key":"4185_CR24","doi-asserted-by":"publisher","unstructured":"Thompson A, Sch\u00e4fer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK, Hamon C. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS. Anal Chem. 2003;75(8):1895\u2009\u2013\u2009904. https:\/\/doi.org\/10.1021\/ac0262560 \u00a0Erratum in: Anal Chem. 2003;75(18):4942. Johnstone, R . Erratum in: Anal Chem. 2006;78(12):4235. Mohammed, A Karim A. PMID: 12713048.","DOI":"10.1021\/ac0262560"},{"issue":"6","key":"4185_CR25","doi-asserted-by":"publisher","first-page":"O111016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet LC, Navarro P, Tate S, R\u00f6st H, Selevsek N, Reiter L, Bonner R, Aebersold R Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteom. 2012;11(6):O111016717. https:\/\/doi.org\/10.1074\/mcp.O111.016717. Epub 2012 Jan 18. PMID: 22261725; PMCID: PMC3433915.","journal-title":"Mol Cell Proteom"},{"issue":"6","key":"4185_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","volume":"117","author":"FR Ueland","year":"2011","unstructured":"Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, Sokoll L, Smith A, van Nagell JR Jr, Zhang Z. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors. Obstet Gynecol. 2011;117(6):1289\u201397. https:\/\/doi.org\/10.1097\/AOG.0b013e31821b5118. PMID: 21606739.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"4185_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/cimb43020074","volume":"43","author":"M Ludvigsen","year":"2021","unstructured":"Ludvigsen M, Thorlacius-Ussing L, Vorum H, Stender MT, Thorlacius-Ussing O, Honor\u00e9 B. Proteomic characterization of colorectal cancer tissue from patients identifies novel putative protein biomarkers. Curr Issues Mol Biol. 2021;43(2):1043\u201356. https:\/\/doi.org\/10.3390\/cimb43020074. PMID: 34563043; PMCID: PMC8929084.","journal-title":"Curr Issues Mol Biol"},{"key":"4185_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12957-021-02423-y","volume":"19","author":"J Pillai","year":"2021","unstructured":"Pillai J, Chincholkar T, Dixit R, et al. A systematic review of proteomic biomarkers in oral squamous cell cancer. World J Surg Onc. 2021;19:315. https:\/\/doi.org\/10.1186\/s12957-021-02423-y.","journal-title":"World J Surg Onc"},{"issue":"1","key":"4185_CR29","doi-asserted-by":"publisher","first-page":"e1700179","DOI":"10.1002\/prca.201700179","volume":"13","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Zhu J, Lu C, Zhang Q, Xie W, Sun P, Dong X, Yue L, Sun Y, Yi X, Zhu T, Ruan G, Aebersold R, Huang S, Guo T. Identification of protein abundance changes in hepatocellular carcinoma tissues using PCT-SWATH. Proteom Clin Appl. 2019;13(1):e1700179. https:\/\/doi.org\/10.1002\/prca.201700179. Epub 2018 Nov 19. PMID: 30365225.","journal-title":"Proteom Clin Appl"},{"issue":"1","key":"4185_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, Petralia F, Li Y, Liang WW, Reva B, Krek A, Ji J, Song X, Liu W, Hong R, Yao L, Blumenberg L, Savage SR, Wendl MC, Wen B, Li K, Tang LC, MacMullan MA, Avanessian SC, Kane MH, Newton CJ, Cornwell M, Kothadia RB, Ma W, Yoo S, Mannan R, Vats P, Kumar-Sinha C, Kawaler EA, Omelchenko T, Colaprico A, Geffen Y, Maruvka YE, da Veiga Leprevost F, Wiznerowicz M, G\u00fcm\u00fc\u015f ZH, Veluswamy RR, Hostetter G, Heiman DI, Wyczalkowski MA, Hiltke T, Mesri M, Kinsinger CR, Boja ES, Omenn GS, Chinnaiyan AM, Rodriguez H, Li QK, Jewell SD, Thiagarajan M, Getz G, Zhang B, Feny\u00f6 D, Ruggles KV, Cieslik MP, Robles AI, Clauser KR, Govindan R, Wang P, Nesvizhskii AI, Ding L, Mani DR, Carr SA. Clinical proteomic tumor analysis Consortium. Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell. 2020;182(1):200\u2013e22535. https:\/\/doi.org\/10.1016\/j.cell.2020.06.013. PMID: 32649874; PMCID: PMC7373300.","journal-title":"Cell"},{"issue":"1","key":"4185_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10585-013-9614-5","volume":"31","author":"DM Roque","year":"2014","unstructured":"Roque DM, Buza N, Glasgow M, Bellone S, Bortolomai I, Gasparrini S, Cocco E, Ratner E, Silasi DA, Azodi M, Rutherford TJ, Schwartz PE, Santin AD. Class III \u03b2-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin\/paclitaxel. Clin Exp Metastasis. 2014;31(1):101\u201310. Epub 2013 Sep 5. PMID: 24005572; PMCID: PMC3947146.","journal-title":"Clin Exp Metastasis"},{"key":"4185_CR32","doi-asserted-by":"publisher","unstructured":"Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M, Winget M, Yasui Y. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst. 2001;93(14):1054-61. https:\/\/doi.org\/10.1093\/jnci\/93.14.1054. PMID: 11459866.","DOI":"10.1093\/jnci\/93.14.1054"},{"issue":"10","key":"4185_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJMoa0810699","volume":"361","author":"TS Mok","year":"2009","unstructured":"Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, Saijo N, Sunpaweravong P, Han B, Margono B, Ichinose Y, Nishiwaki Y, Ohe Y, Yang JJ, Chewaskulyong B, Jiang H, Duffield EL, Watkins CL, Armour AA, Fukuoka M. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009;361(10):947\u201357. https:\/\/doi.org\/10.1056\/NEJMoa0810699. Epub 2009 Aug 19. PMID: 19692680.","journal-title":"N Engl J Med"},{"key":"4185_CR34","unstructured":"FDA. FDA authorizes first next generation sequencing-based test to detect very low levels of remaining cancer cells in patients with acute lymphoblastic leukemia or multiple myeloma. (2018). FDA News Release. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-authorizes-first-next-generation-sequencing-based-test-detect-very-low-levels-remaining-cancer [Accessed 10 Jul 2025]."},{"issue":"4","key":"4185_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nmeth.1307","volume":"6","author":"TE Druley","year":"2009","unstructured":"Druley TE, Vallania FL, Wegner DJ, Varley KE, Knowles OL, Bonds JA, Robison SW, Doniger SW, Hamvas A, Cole FS, Fay JC, Mitra RD. Quantification of rare allelic variants from pooled genomic DNA. Nat Methods. 2009;6(4):263\u20135. https:\/\/doi.org\/10.1038\/nmeth.1307. Epub 2009 Mar 1. PMID: 19252504; PMCID: PMC2776647.","journal-title":"Nat Methods"},{"issue":"10","key":"4185_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Cancer Genome Atlas Research Network, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The cancer genome atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113\u201320. https:\/\/doi.org\/10.1038\/ng.2764. PMID: 24071849; PMCID: PMC3919969.","journal-title":"Nat Genet"},{"key":"4185_CR37","doi-asserted-by":"publisher","unstructured":"Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359(9306):572-7. https:\/\/doi.org\/10.1016\/S0140-6736(02)07746-2. PMID: 11867112.","DOI":"10.1016\/S0140-6736(02)07746-2"},{"key":"4185_CR38","doi-asserted-by":"publisher","unstructured":"Addona TA, Abbatiello SE, Schilling B, Skates SJ, Mani DR, Bunk DM, Spiegelman CH, Zimmerman LJ, Ham AJ, Keshishian H, Hall SC, Allen S, Blackman RK, Borchers CH, Buck C, Cardasis HL, Cusack MP, Dodder NG, Gibson BW, Held JM, Hiltke T, Jackson A, Johansen EB, Kinsinger CR, Li J, Mesri M, Neubert TA, Niles RK, Pulsipher TC, Ransohoff D, Rodriguez H, Rudnick PA, Smith D, Tabb DL, Tegeler TJ, Variyath AM, Vega-Montoto LJ, Wahlander A, Waldemarson S, Wang M, Whiteaker JR, Zhao L, Anderson NL, Fisher SJ, Liebler DC, Paulovich AG, Regnier FE, Tempst P, Carr SA. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009;27(7):633\u2009\u2013\u200941. https:\/\/doi.org\/10.1038\/nbt.1546. Epub 2009 Jun 28. Erratum in: Nat Biotechnol. 2009;27(9):864. PMID: 19561596; PMCID: PMC2855883.","DOI":"10.1038\/nbt.1546"},{"issue":"1","key":"4185_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrg2626","volume":"11","author":"ML Metzker","year":"2010","unstructured":"Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11(1):31\u201346. https:\/\/doi.org\/10.1038\/nrg2626. Epub 2009 Dec 8. PMID: 19997069.","journal-title":"Nat Rev Genet"},{"key":"4185_CR40","doi-asserted-by":"publisher","unstructured":"Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347\u2009\u2013\u200955. https:\/\/doi.org\/10.1038\/nature19949. PMID: 27629641.","DOI":"10.1038\/nature19949"},{"issue":"4","key":"4185_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of Circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223\u201338. https:\/\/doi.org\/10.1038\/nrc.2017.7. Epub 2017 Feb 24. PMID: 28233803.","journal-title":"Nat Rev Cancer"},{"key":"4185_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12014-018-9200-6","volume":"15","author":"V Drendel","year":"2018","unstructured":"Drendel V, Heckelmann B, Schell C, et al. Proteomic distinction of renal Oncocytomas and chromophobe renal cell carcinomas. Clin Proteom. 2018;15:25. https:\/\/doi.org\/10.1186\/s12014-018-9200-6.","journal-title":"Clin Proteom"},{"key":"4185_CR43","doi-asserted-by":"publisher","unstructured":"Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115\u2013118. https:\/\/doi.org\/10.1038\/nature21056. Epub 2017 Jan 25. Erratum in: Nature. 2017;546(7660):686. doi: 10.1038\/nature22985. PMID: 28117445; PMCID: PMC8382232.","DOI":"10.1038\/nature21056"},{"issue":"6121","key":"4185_CR44","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR\/Cas systems. Science. 2013;339(6121):819\u201323. https:\/\/doi.org\/10.1126\/science.1231143. Epub 2013 Jan 3. PMID: 23287718; PMCID: PMC3795411.","journal-title":"Science"},{"issue":"27","key":"4185_CR45","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S van \u2018t Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, van \u2018t Veer LJ, Dai H, van de Vijver MJ, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.","journal-title":"N Engl J Med"},{"issue":"4","key":"4185_CR46","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","volume":"23","author":"H Davies","year":"2017","unstructured":"Davies H, Glodzik D, Morganella S, et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med. 2017;23(4):517\u201325.","journal-title":"Nat Med"},{"issue":"10","key":"4185_CR47","first-page":"e1001880","volume":"12","author":"RB Lanman","year":"2015","unstructured":"Lanman RB, Mortimer SA, Zill OA, et al. Analytical and clinical validation of a digital sequencing panel for detection of circulating tumor DNA. PLoS Med. 2015;12(10):e1001880.","journal-title":"PLoS Med"},{"issue":"11","key":"4185_CR48","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton GM, Fichtenholtz A, Otto GA, Wang K, Downing SR, He J, Schnall-Levin M, White J, Sanford EM, An P, Sun J, Juhn F, Brennan K, Iwanik K, Maillet A, Buell J, White E, Zhao M, Balasubramanian S, Terzic S, Richards T, Banning V, Garcia L, Mahoney K, Zwirko Z, Donahue A, Beltran H, Mosquera JM, Rubin MA, Dogan S, Hedvat CV, Berger MF, Pusztai L, Lechner M, Boshoff C, Jarosz M, Vietz C, Parker A, Miller VA, Ross JS, Curran J, Cronin MT, Stephens PJ, Lipson D, Yelensky R. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol. 2013;31(11):1023\u201331. https:\/\/doi.org\/10.1038\/nbt.2696. Epub 2013 Oct 20. PMID: 24142049; PMCID: PMC5710001.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"4185_CR49","doi-asserted-by":"publisher","first-page":"e0140712","DOI":"10.1371\/journal.pone.0140712","volume":"10","author":"RB Lanman","year":"2015","unstructured":"Lanman RB, Mortimer SA, Zill OA, et al. Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free Circulating tumor DNA. PLoS ONE. 2015;10(10):e0140712.","journal-title":"PLoS ONE"},{"key":"4185_CR50","doi-asserted-by":"publisher","unstructured":"Carter P et al. Jan. Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients? Oncotarget vol. 9,10 9456\u20139467. 16 2018, https:\/\/doi.org\/10.18632\/oncotarget.24258","DOI":"10.18632\/oncotarget.24258"},{"issue":"24","key":"4185_CR51","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.18632\/oncotarget.26797","volume":"10","author":"N Beaubier","year":"2019","unstructured":"Beaubier N, Tell R, Lau D. Clinical validation of the tempus xT next-generation targeted oncology sequencing assay. Oncotarget. 2019;10(24):2384\u201396.","journal-title":"Oncotarget"},{"key":"4185_CR52","doi-asserted-by":"publisher","unstructured":"Zehir A, Benayed R, Shah RH, Syed A, Middha S, Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J, Mandelker DL, Cheng DT, Chandramohan R, Mohanty AS, Ptashkin RN, Jayakumaran G, Prasad M, Syed MH, Rema AB, Liu ZY, Nafa K, Borsu L, Sadowska J, Casanova J, Bacares R, Kiecka IJ, Razumova A, Son JB, Stewart L, Baldi T, Mullaney KA, Al-Ahmadie H, Vakiani E, Abeshouse AA, Penson AV, Jonsson P, Camacho N, Chang MT, Won HH, Gross BE, Kundra R, Heins ZJ, Chen HW, Phillips S, Zhang H, Wang J, Ochoa A, Wills J, Eubank M, Thomas SB, Gardos SM, Reales DN, Galle J, Durany R, Cambria R, Abida W, Cercek A, Feldman DR, Gounder MM, Hakimi AA, Harding JJ, Iyer G, Janjigian YY, Jordan EJ, Kelly CM, Lowery MA, Morris LGT, Omuro AM, Raj N, Razavi P, Shoushtari AN, Shukla N, Soumerai TE, Varghese AM, Yaeger R, Coleman J, Bochner B, Riely GJ, Saltz LB, Scher HI, Sabbatini PJ, Robson ME, Klimstra DS, Taylor BS, Baselga J, Schultz N, Hyman DM, Arcila ME, Solit DB, Ladanyi M, Berger MF. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23(6):703\u2013713. https:\/\/doi.org\/10.1038\/nm.4333. Epub 2017 May 8. Erratum in: Nat Med. 2017;23(8):1004. doi: 10.1038\/nm0817-1004c. PMID: 28481359; PMCID: PMC5461196.","DOI":"10.1038\/nm.4333"},{"issue":"6","key":"4185_CR53","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","volume":"31","author":"MC Liu","year":"2020","unstructured":"Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV, CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol. 2020;31(6):745\u201359. https:\/\/doi.org\/10.1016\/j.annonc.2020.02.011. Epub 2020 Mar 30. PMID: 33506766; PMCID: PMC8274402.","journal-title":"Ann Oncol"},{"issue":"26","key":"4185_CR54","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2012-07-444042","volume":"120","author":"M Faham","year":"2012","unstructured":"Faham M, Zheng J, Moorhead M, Carlton VE, Stow P, Coustan-Smith E, Pui CH, Campana D. Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2012;120(26):5173\u201380. https:\/\/doi.org\/10.1182\/blood-2012-07-444042. Epub 2012 Oct 16. PMID: 23074282; PMCID: PMC3537310.","journal-title":"Blood"},{"issue":"9","key":"4185_CR55","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1158\/2767-9764.CRC-25-0171","volume":"5","author":"H Ghani","year":"2025","unstructured":"Ghani H, et al. GPSai: A clinically validated AI tool for tissue of origin prediction during routine tumor profiling. Cancer Res Commun Vol. 2025;5(9):1477\u201389. https:\/\/doi.org\/10.1158\/2767-9764.CRC-25-0171.","journal-title":"Cancer Res Commun Vol"},{"key":"4185_CR56","doi-asserted-by":"publisher","unstructured":"McKiernan J et al. A novel urine exosome gene expression assay to predict High-grade prostate cancer at initial biopsy. JAMA Oncol 2,7 (2016): 882\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0097","DOI":"10.1001\/jamaoncol.2016.0097"},{"issue":"2","key":"4185_CR57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1001\/jamaoncol.2018.4616","volume":"5","author":"DL Steward","year":"2019","unstructured":"StewardDL, Carty SE, Sippel RS, Yang SP, Sosa JA, Sipos JA, Figge JJ, Mandel S, Haugen BR, Burman KD, Baloch ZW, Lloyd RV, Seethala RR, Gooding WE, Chiosea SI, Gomes-Lima C, Ferris RL, Folek JM, Khawaja RA, Kundra P, Loh KS, Marshall CB, Mayson S, McCoy KL, Nga ME, Ngiam KY, Nikiforova MN, Poehls JL, Ringel MD, Yang H, Yip L, Nikiforov YE. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study. JAMA Oncol. 2019;5(2):204\u201312. https:\/\/doi.org\/10.1001\/jamaoncol.2018.4616 Erratum in:JAMA Oncol. 2019 Feb 1;5(2):271. doi: 10.1001\/jamaoncol.2018.6413. PMID: 30419129; PMCID: PMC6439562.","journal-title":"JAMA Oncol"},{"key":"4185_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","volume":"1","author":"MD Abr\u00e0moff","year":"2018","unstructured":"Abr\u00e0moff MD, Lavin PT, Birch M, Shah N, Folk JC. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. 2018;1:39. https:\/\/doi.org\/10.1038\/s41746-018-0040-6. PMID: 31304320; PMCID: PMC6550188.","journal-title":"NPJ Digit Med"},{"issue":"8","key":"4185_CR59","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella G, Hanna MG, Geneslaw L, Miraflor A, Werneck Krauss Silva V, Busam KJ, Brogi E, Reuter VE, Klimstra DS, Fuchs TJ. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat Med. 2019;25(8):1301\u20139. https:\/\/doi.org\/10.1038\/s41591-019-0508-1. Epub 2019 Jul 15. PMID: 31308507; PMCID: PMC7418463.","journal-title":"Nat Med"},{"issue":"5","key":"4185_CR60","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.pathol.2024.02.009","volume":"56","author":"K Lami","year":"2024","unstructured":"Lami K, Yoon HS, Parwani AV, Pham HH, Tachibana Y, Linhart C, Grinwald M, Vecsler M, Fukuoka J. Validation of prostate and breast cancer detection artificial intelligence algorithms for accurate histopathological diagnosis and grading: a retrospective study with a Japanese cohort. Pathology. 2024;56(5):633\u201342.","journal-title":"Pathology"},{"issue":"7697","key":"4185_CR61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D von Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Nature., Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, H\u00f6lsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Br\u00fcck W, Hofer S, Brehmer S, Seiz-Rosenhagen M, H\u00e4nggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, M\u00fchleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, M\u00fcller HL, Rutkowski S, von Hoff K, Fr\u00fchwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Bl\u00fcmcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Sch\u00fcller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555(7697):469\u201374. https:\/\/doi.org\/10.1038\/nature26000 doi:10.1038\/nature26000. Epub 2018 Mar 14. PMID: 29539639; PMCID: PMC6093218.","journal-title":"Nature"},{"key":"4185_CR62","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41591-023-02252-4","volume":"29","author":"T Hollon","year":"2023","unstructured":"Hollon T, Jiang C, Chowdury A, et al. Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging. Nat Med. 2023;29:828\u201332. https:\/\/doi.org\/10.1038\/s41591-023-02252-4.","journal-title":"Nat Med"},{"issue":"4","key":"4185_CR63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","volume":"23","author":"H Davies","year":"2017","unstructured":"Davies H, Glodzik D, Morganella S, Yates LR, Staaf J, Zou X, Ramakrishna M, Martin S, Boyault S, Sieuwerts AM, Simpson PT, King TA, Raine K, Eyfjord JE, Kong G, Borg \u00c5, Birney E, Stunnenberg HG, van de Vijver MJ, B\u00f8rresen-Dale AL, Martens JW, Span PN, Lakhani SR, Vincent-Salomon A, Sotiriou C, Tutt A, Thompson AM, Van Laere S, Richardson AL, Viari A, Campbell PJ, Stratton MR, Nik-Zainal S. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med. 2017;23(4):517\u201325. https:\/\/doi.org\/10.1038\/nm.4292. Epub 2017 Mar 13. PMID: 28288110; PMCID: PMC5833945.","journal-title":"Nat Med"},{"issue":"10","key":"4185_CR64","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s41591-018-0177-5","volume":"24","author":"N Coudray","year":"2018","unstructured":"Coudray N, Ocampo PS, Sakellaropoulos T, Narula N, Snuderl M, Feny\u00f6 D, Moreira AL, Razavian N, Tsirigos A. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med. 2018;24(10):1559\u201367. https:\/\/doi.org\/10.1038\/s41591-018-0177-5. Epub 2018 Sep 17. PMID: 30224757; PMCID: PMC9847512.","journal-title":"Nat Med"},{"key":"4185_CR65","doi-asserted-by":"publisher","unstructured":"Lauss M, Donia M, Harbst K, Andersen R, Mitra S, Rosengren F, Salim M, Vallon-Christersson J, T\u00f6rngren T, Kvist A, Ringn\u00e9r M, Svane IM, J\u00f6nsson G. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma. Nat Commun. 2017;8(1):1738. https:\/\/doi.org\/10.1038\/s41467-017-01460-0. Erratum in: Nat Commun. 2020;11(1):1714. doi: 10.1038\/s41467-020-15531-2. PMID: 29170503; PMCID: PMC5701046.","DOI":"10.1038\/s41467-017-01460-0"},{"issue":"1","key":"4185_CR66","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1186\/s12885-024-13190-w","volume":"24","author":"J Koyama","year":"2024","unstructured":"Koyama J, Morise M, Furukawa T, Oyama S, Matsuzawa R, Tanaka I, Wakahara K, Yokota H, Kimura T, Shiratori Y, Kondoh Y, Hashimoto N, Ishii M. Artificial intelligence-based personalized survival prediction using clinical and radiomics features in patients with advanced non-small cell lung cancer. BMC Cancer. 2024;24(1):1417. https:\/\/doi.org\/10.1186\/s12885-024-13190-w. PMID: 39558311; PMCID: PMC11572056.","journal-title":"BMC Cancer"},{"issue":"15","key":"4185_CR67","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.3390\/cancers14153798","volume":"14","author":"KY Hou","year":"2022","unstructured":"Hou KY, Chen JR, Wang YC, Chiu MH, Lin SP, Mo YH, Peng SC, Lu CF. Radiomics-Based deep learning prediction of overall survival in Non-Small-Cell lung cancer using Contrast-Enhanced computed tomography. Cancers (Basel). 2022;14(15):3798. https:\/\/doi.org\/10.3390\/cancers14153798. PMID: 35954461; PMCID: PMC9367244.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"4185_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11547-024-01919-3","volume":"130","author":"T Luo","year":"2025","unstructured":"Luo T, Yan M, Zhou M, Dekker A, Appelt AL, Ji Y, Zhu J, de Ruysscher D, Wee L, Zhao L, Zhang Z. Improved prognostication of overall survival after radiotherapy in lung cancer patients by an interpretable machine learning model integrating lung and tumor radiomics and clinical parameters. Radiol Med. 2025;130(1):96\u2013109. https:\/\/doi.org\/10.1007\/s11547-024-01919-3. Epub 2024 Nov 14. PMID: 39542968.","journal-title":"Radiol Med"},{"issue":"1","key":"4185_CR69","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13244-023-01438-1","volume":"14","author":"Z Jiang","year":"2023","unstructured":"Jiang Z, Xie W, Zhou X, Pan W, Jiang S, Zhang X, Zhang M, Zhang Z, Lu Y, Wang D. A virtual biopsy study of microsatellite instability in gastric cancer based on deep learning radiomics. Insights Imaging. 2023;14(1):104. https:\/\/doi.org\/10.1186\/s13244-023-01438-1. PMID: 37286810; PMCID: PMC10247640.","journal-title":"Insights Imaging"},{"issue":"2","key":"4185_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, Gottardo R, Hahne F, Hansen KD, Irizarry RA, Lawrence M, Love MI, MacDonald J, Obenchain V, Ole\u015b AK, Pag\u00e8s H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M. Orchestrating high-throughput genomic analysis with bioconductor. Nat Methods. 2015;12(2):115\u201321. https:\/\/doi.org\/10.1038\/nmeth.3252. PMID: 25633503; PMCID: PMC4509590.","journal-title":"Nat Methods"},{"key":"4185_CR71","doi-asserted-by":"publisher","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401-4. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095. Erratum in: Cancer Discov. 2012;2(10):960. PMID: 22588877; PMCID: PMC3956037.","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"4185_CR72","doi-asserted-by":"publisher","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, Olsson I, Edlund K, Lundberg E, Navani S, Szigyarto CA, Odeberg J, Djureinovic D, Takanen JO, Hober S, Alm T, Edqvist PH, Berling H, Tegel H, Mulder J, Rockberg J, Nilsson P, Schwenk JM, Hamsten M, von Feilitzen K, Forsberg M, Persson L, Johansson F, Zwahlen M, von Heijne G, Nielsen J, Pont\u00e9n F. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. https:\/\/doi.org\/10.1126\/science.1260419. PMID: 25613900.","DOI":"10.1126\/science.1260419"},{"issue":"5","key":"4185_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/gm247","volume":"3","author":"N Navin","year":"2011","unstructured":"Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med. 2011;3(5):31. https:\/\/doi.org\/10.1186\/gm247. PMID: 21631906; PMCID: PMC3219072.","journal-title":"Genome Med"},{"key":"4185_CR74","doi-asserted-by":"publisher","unstructured":"Zhang, Zheng M, Hu Y, Gou R, Wang J, Nie X, Li X, Liu Q, Liu J, Lin B et al. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma. Aging (Albany NY). 2019;11(12):4198\u20134215. https:\/\/doi.org\/10.18632\/aging.102047. PMID: 31257224; PMCID: PMC6629004.","DOI":"10.18632\/aging.102047"},{"key":"4185_CR75","doi-asserted-by":"publisher","unstructured":"Slamon DJ, Godolphin W, Jones LA et al. Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science (New York, N.Y.). 1989;244(4905):707\u2013712. https:\/\/doi.org\/10.1126\/science.2470152. PMID: 2470152.","DOI":"10.1126\/science.2470152"},{"issue":"10071","key":"4185_CR76","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, Gabe R, Kaplan R, Parmar MK, Collaco-Moraes Y, Ward K, Hindley RG, Freeman A, Kirkham AP, Oldroyd R, Parker C, Emberton M, PROMIS study group. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(16)32401-1. Epub 2017 Jan 20. PMID: 28110982.","journal-title":"Lancet"},{"key":"4185_CR77","doi-asserted-by":"publisher","unstructured":"Li L, Sun Y. Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges. MedComm (2020). 2024;5(11):e766. https:\/\/doi.org\/10.1002\/mco2.766. PMID: 39525954; PMCID: PMC11550092.","DOI":"10.1002\/mco2.766"},{"key":"4185_CR78","doi-asserted-by":"publisher","first-page":"104830","DOI":"10.1016\/j.critrevonc.2025.104830","volume":"214","author":"D Das","year":"2025","unstructured":"Das D, Singh P, Pal M, Pandey M, Dixit R. Global perspective on the genetic, epigenetic, and transcriptomic basis of gallbladder cancer. Crit Rev Oncol\/Hematol. 2025;214:104830. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104830.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"4185_CR79","doi-asserted-by":"publisher","unstructured":"Karapetis CS, Khambata-Ford S, Jonker DJ, O\u2019Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359(17):1757-65. https:\/\/doi.org\/10.1056\/NEJMoa0804385. PMID: 18946061.","DOI":"10.1056\/NEJMoa0804385"},{"issue":"6892","key":"4185_CR80","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949\u201354. https:\/\/doi.org\/10.1038\/nature00766. Epub 2002 Jun 9. PMID: 12068308.","journal-title":"Nature"},{"issue":"12","key":"4185_CR81","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","volume":"7","author":"AA Chaudhuri","year":"2017","unstructured":"Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, Dudley JC, Binkley MS, Modlin L, Padda SK, Gensheimer MF, West RB, Shrager JB, Neal JW, Wakelee HA, Loo BW Jr, Alizadeh AA, Diehn M. Early detection of molecular residual disease in localized lung cancer by Circulating tumor DNA profiling. Cancer Discov. 2017;7(12):1394\u2013403. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0716. Epub 2017 Sep 24. PMID: 28899864; PMCID: PMC5895851.","journal-title":"Cancer Discov"},{"issue":"9747","key":"4185_CR82","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(10)61152-X","volume":"376","author":"P Farmer","year":"2010","unstructured":"Farmer P, Frenk J, Knaul FM, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010;376(9747):1186\u201393.","journal-title":"Lancet"},{"issue":"11","key":"4185_CR83","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1470-2045(15)00223-5","volume":"16","author":"R Sullivan","year":"2015","unstructured":"Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16(11):1193\u2013224.","journal-title":"Lancet Oncol"},{"issue":"12","key":"4185_CR84","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1001\/jamaoto.2014.1570","volume":"140","author":"T Fojo","year":"2014","unstructured":"Fojo T, Mailankody S, Lo A. Unintended consequences of expensive cancer therapeutics-the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity: the John Conley lecture. JAMA Otolaryngol Head Neck Surg. 2014;140(12):1225\u201336.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"4185_CR85","first-page":"256","volume":"3","author":"G Rivera-Col\u00f3n","year":"2017","unstructured":"Rivera-Col\u00f3n G, Chapman JS, White J, et al. Implementation of targeted next-generation sequencing panels in developing countries: opportunities and challenges. J Glob Oncol. 2017;3(3):256\u201363.","journal-title":"J Glob Oncol"},{"issue":"7","key":"4185_CR86","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","volume":"15","author":"A Koch","year":"2018","unstructured":"Koch A, Joosten SC, Feng Z, et al. Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol. 2018;15(7):459\u201366.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7589","key":"4185_CR87","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature16996","volume":"530","author":"J Quick","year":"2016","unstructured":"Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature. 2016;530(7589):228\u201332.","journal-title":"Nature"},{"issue":"W1","key":"4185_CR88","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan E, Baker D, Batut B, et al. The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 2018;46(W1):W537\u201344.","journal-title":"Nucleic Acids Res"},{"key":"4185_CR89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-020-00744-3","volume":"12","author":"D Lin","year":"2020","unstructured":"Lin D, Alpert A, Chen K. Establishing regional biobanks to advance genomic medicine: challenges and opportunities. Genome Med. 2020;12:51.","journal-title":"Genome Med"},{"issue":"6","key":"4185_CR90","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/jclinpath-2017-204808","volume":"71","author":"BJ Williams","year":"2018","unstructured":"Williams BJ, DaCosta P, Goacher E, et al. A systematic review of the benefits and challenges of digital pathology and telepathology. J Clin Pathol. 2018;71(6):463\u20139.","journal-title":"J Clin Pathol"},{"key":"4185_CR91","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13073-016-0342-8","volume":"8","author":"MW Schmitt","year":"2016","unstructured":"Schmitt MW, Loeb LA, Salk JJ. The potential of DNA sequencing-based detection of low-frequency mutations in cancer. Genome Med. 2016;8:89.","journal-title":"Genome Med"},{"key":"4185_CR92","doi-asserted-by":"publisher","unstructured":"Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012;12(5):323\u2009\u2013\u200934. https:\/\/doi.org\/10.1038\/nrc3261. PMID: 22513401.","DOI":"10.1038\/nrc3261"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04185-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04185-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:15:23Z","timestamp":1771420523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04185-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4185"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04185-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree that the work will be published in a journal and understand and agree to the full terms and conditions of its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}